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Rheumatic and Musculoskeletal Diseases (RMDs) are chronic
conditions that affect a substantial number of people. RMDs are
significantly related to co-morbidity. Therefore, focusing on pre-
vention in RMDs is of importance to promote and maintain health.
Prevention includes primary-, secondary-, tertiary-, and clinical
prevention. Primary prevention aims to prevent the onset of dis-
ease before the disease process begins, secondary prevention in-
cludes detecting and reducing disease and risk factors at the
earliest possible point, and tertiary prevention aims to limit the
influence of a recognized or verified disease and to address or
reduce further development or worsening of the disease, including
physical and psychosocial disability. Clinical prevention attempts
to integrate prevention into the disease management to limit
disease progression and prevent complications and relapse. This
chapter will focus on the evidence for prevention and highlight
how innovations and trends can contribute by using digital tech-
nologies as an example.
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Rheumatic and musculoskeletal diseases (RMD) comprise a diverse group of diseases that
commonly affect the joints and includes, for example, rheumatoid arthritis, psoriasis arthritis, and
spondyloarthritis. RMDs are in most cases chronic diseases and affect a substantial number of people
[1]. RMDs increase health care costs for the individual patient and for society [2]. In addition, RMDs are
significantly related to co-morbidity. For instance, a Danish nationwide register study found that pa-
tients with seropositive rheumatoid arthritis (RA) had higher odds for several co-morbidities prior to
and, particularly, after the diagnosis of RA [3]. Hence, a two-fold higher risk of cardiovascular disease
was found in patients with e.g. RA compared with the general population [4]. Consequently, a lower
overall survival resulting in high risk of premature death is reported [5]. Therefore, focusing on pre-
vention in RMDs is of importance to promote and maintain health.
Prevention includes, among other things, primary prevention, secondary prevention, tertiary pre-
vention [6,7], and clinical prevention. Primary prevention aims to prevent the onset of disease before
the disease process begins by eliminating specific risk factors or increasing an individual's resistance to
the condition. Vaccines against infections are a good example of primary prevention. Also, good dental
hygiene and teaching sexual health in school relate to primary prevention.
Secondary prevention includes detecting and reducing disease and risk factors at the earliest possible
point. Thus, secondary preventive intervention includes measures that can lead to early diagnosis and
start up treatment of disease. An example of secondary prevention includes early identification of
cancers through screening programs such asmammograms and colonoscopies, but also early detection
of patients with chronic obstructive pulmonary disease (COPD) in general practice is related to sec-
ondary prevention. Secondary prevention typically takes place in the primary health sector, but also in
hospitals and in other sectors (e.g. education and social sectors).
The aim of tertiary prevention is to limit the influence of a recognized or verified disease and to
prevent further development or worsening of the disease, including physical and psychosocial
disability. Tertiary prevention is defined within the frame of the disease, while rehabilitation is defined
from the patient's overall situation including own needs and desires. Tertiary prevention is often a
natural part of rehabilitation. Examples of tertiary prevention include prevention of (new) fractures in
patients with osteoporosis, hygiene instruction for patients with oral disease, interviews with the
general practitioners or other health professionals for smoking cessation in patients with e.g. chronic
obstructive pulmonary disease, or promotion of physical activity in patients with RMDs who are at
increased risk of cardiovascular disease.
Clinical prevention is an additional way of thinking about prevention. The intention of clinical
prevention is to focus on and integrate this approach into the disease management to limit disease
progression and prevent complications and relapse, thus achieving the greatest possible disease
management and quality of life. Clinical prevention takes place in the health care system and is based
on patient activation and involvement. The efforts and interventions therefore also include elements of
health promotion and rehabilitation. In clinical prevention, the actors are health professionals in
interaction with the patients who are always the target group. Examples of clinical prevention are
initiatives in clinical care such as smoking cessation during pregnancy, pre-surgery alcohol withdrawal,
physical activity programs for the mentally ill, and diabetes educational programs.
Prevention and RMDs
It is a relatively new option to discuss prevention in rheumatology. However, with increasing
knowledge about the development of RMDs and knowledge of the best treatment and treatment
outcomes, prevention has become increasingly relevant for health professionals targeting the healthy
population, as well as patients with RMDs.
It is well-accepted that there is a pre-clinical period in which the RMD is under development,
however asymptomatic [8]. This can be detected in e.g. biomarkers or other processes as, for instance,
Periodontal Disease. Furthermore, there is an increasing focus on the challenge of delay of diagnosis,
often affecting people with RMDs [9]. Therefore, the European League against Rheumatism (EULAR)
among others has, during the past years, and will, in the coming future, continue to create awareness
B.A. Esbensen et al. / Best Practice & Research Clinical Rheumatology 34 (2020) 101525 3about RMDs and RMD symptoms among the public, in primary health care, and among general
practitioners in order to detect diagnosis early. Since 1996, October 12 is recognized as World Arthritis
Day, a global initiative bringing people together to raise awareness of RMDs. This is a strategy to
highlight arthritis in general, but also to create awareness of e.g. early symptoms of arthritis. The
relevance of such an initiative is emphasized by the fact that a period of 12 weeks between symptom
onset and anti-inflammatory medical treatment start is recommended [10]. The longer it takes for the
patient to start up medical treatment, the higher the risk of joint destruction and following loss of
function [8]. However, meeting the early treatment recommendation is not the case for all patients as
demonstrated in a cross-sectional study among 482 patients with RA from a total of eight countries
which showed that the median delay for start of medical treatment was 24weeks [9]. Future directions
in the coming decades may improve disease screening and prevention for people with RMDs. It might
be that more screening and preventive approaches for some inflammatory rheumatic diseases will be a
reality within the next decade.
To illustrate prevention in relation to RMDs, smoking is an excellent example. The number of
smokers among people with RMDs worldwide is unknown. However, surveys based on Danish people
with rheumatoid arthritis suggest that 25e30% of the people in this patient group smoke [11,12].
Several studies have identified smoking as a factor associatedwith development of RA in thosewho are
Anti-CCP positive [13,14]. The risk of developing RA is approximately twice as high among smokers as
in non-smokers [13]. Many patients with RMDs are not aware of this risk. It is also well known that
smoking is harmful and life-threatening, for example in relation to the development of cardiovascular
diseases and cancer. Unfortunately, smoking as a factor in the development of RMDs is not widely
known among the larger population or people with RMDs. Therefore, the primary prevention for the
development of RMDs is that people do not start smoking. This should be included in health campaigns
and teaching in, for example, schools and youth education.
If a person has already developed an RMD and is smoking, it is invaluable that the person stops
smoking. Supporting this would fall under both the secondary prevention and clinical prevention.
Knowledge of the risk factors for rheumatic diseases is growing (e.g. smoking for RA) [15]. Smoking
among people with RA is associated with a quicker disease progression and decreased benefit of the
medical treatment [16e18]. It is also suggested that smokers with RA experienceworse disease specific
outcomes, including increased inflammation and higher disease activity [19,20] compared to non-
smokers due to attenuated responses to anti-rheumatic treatments. As previously mentioned, smok-
ing is a major risk factor for the development of cardiovascular disease (CVD), and smoking is an in-
dependent risk factor for developing CVD which underlines the need for smoking cessation in this
patient population [21]. A recently published study based on data from ten different countries found
that smoking cessation in patients with RA was associated with lower disease activity and improved
lipid profiles and could predict reduced rates of CVD events. This underlines the need for health
professionals in rheumatology departments as well as in the primary care sector, including GPs, to
inform patients with RMDs how risky smoking is for their medical arthritis treatment and for the
development of CVD. Unfortunately, the evidence of interventions for smoking cessation in peoplewith
RMDs is scarce. A Cochrane review from 2019 [22] identified only two intervention studies that had
investigated smoking cessation interventions in people with RMDs. Also, the evidence of investigations
into the efficacy of smoking cessation interventions specifically in people with RMDs was of poor
quality. Given the severity of smoking in patients with RMDs, addressing smoking cessation in clinical
practice in this patient group is of great importance. Health professionals and rheumatologists need to
be proactive in both informing patients about the impact of smoking and counselling patients in
smoking cessation.
Tertiary prevention in RMDs
In relation to tertiary prevention, health professionals and rheumatologists focus above all on in-
terventions that prevent disease progression, disability (activity limitations and participation re-
strictions), or premature death after a patient is diagnosed with an RMD. As stated above, tertiary
prevention often includes interventions focusing on self-management-, physical activity, or pain-man-
agement. The nature of all these interventions is that they are active and involve the patient in order to
B.A. Esbensen et al. / Best Practice & Research Clinical Rheumatology 34 (2020) 1015254be effective and sustainable in terms of effect and costs. That the treatment is active refers to the effort
required from the patient, as opposed to a passive treatment where a patient is only a receiver of
treatment given by someone else.
Self-management strategies are of utmost importance for patients to acquire in managing a chronic
disease [23,24]. Essential elements of self-management are self-regulation strategies such as goal
setting, action-planning, self-monitoring, feed-back and relapse prevention; generic competencies
which can be used in the management of any condition or behavior. Tam et al. describes the concept as
“a process where patients are actively participating in a variety of activities that contribute to lessening
of the physical and emotional impact of their illness. Such activities include adhering to their treatment
plan, being physically active, and seeking medical help when the treatment target is not met” [25]. The
Chronic Disease Self-Management Program (CDSMP) is perhaps the most well-studied self-manage-
ment program [26,27] and has proven effective in patients with arthritis on fatigue, self-efficacy, pain,
and activity limitations among others [28]. The CDSMP program stretches over 6 weeks and is available
for small groups face-to-face, or online [29].
The body of evidence supporting the effects of physical activity is large [30], and EULAR have
recently published guidelines for physical activity in RMDs [31]. Besides the effects on cardiorespira-
tory fitness and muscle strength [30], physical activity reduces the risk of all-cause mortality [32], CVD
[33,34], Type 2-diabetes [35e37], obesity [38e40], different forms of cancer [41e45], osteoporosis
[46,47], dementia [32,48,49], and depression [32,50]. In medically well-controlled RA, it seems that the
functional mechanisms of exercise are the same as in the general population with exercise leading to
reduced levels of pro-inflammatory cytokines, such as tumor necrosis factor [51]. Exercise can also
have a positive effect on cachexia by increasing the proportion of fat-free bodymass in patients with RA
[51].
Regarding pain management, the EULAR recommendations for the health professional's approach
to pain management in inflammatory arthritis and osteoarthritis [52] summarizes key aspects for the
health professional to focus on in the management of pain. Emphasis is put on adoption of a patient-
centered framework within a biopsychosocial perspective, sufficient knowledge of both disease and
pain pathogenesis, and ability to differentiate localized and generalized pain. Treatment shall be guided
by scientific evidence and the assessment of the individual patient's needs, preferences, and priorities;
pain characteristics; previous and ongoing pain treatments; inflammation and joint damage; and
psychological and other pain-related factors. The described options of pain treatment suggested were
education complemented by physical activity and exercise, orthotics, psychological and social in-
terventions, sleep hygiene education, weight management, pharmacological and joint-specific treat-
ment options, or interdisciplinary pain management. In terms of effects, physical activity/exercise and
psychological interventions were the types that mostly had positive effects. Educational interventions,
orthotics, weight management, and multidisciplinary treatment can also be effective, but need to be
tailored and targeted towards specific disease groups [52].
Digital technologies to support in tertiary prevention
Digitalization of the health care sector ranges from electronic health records in some healthcare
systems to the numerous amounts of mobile apps and webpages with health-related focus that exist
today. As a consequence, and with the increasing digital presence in society, there is increasing
pressure on the health care sector to work smarter and more cost effectively. This in turn has led to an
increase in the use of digital solutions within health care [53], an increase that is also evident in the
volume of related published scientific literature. A bibliographic-bibliometric analysis on articles
published in Journal of Medical Internet Research revealed 1,797 articles with “digital health” as
keyword [54], most of them published between 2016 and 2019. Digital technologies include apps,
devices, and wearable technology and have a central role in the support of maintenance in lifestyle
interventions in RMDs. The combining of digital technology with behavioral science offers a new
dimension for how behaviors are measured and influenced [55].
For the clinician, the evidence for the use of digitally delivered interventions is of interest, along
withwhat specific apps or webpages have been evaluated in trials, as well as if there are some solutions
that are tailored for specific groups. A systematic review of meta-analyses published in 2017 found 71
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The authors concluded that there is a wide range of effective internet-based programs (on substance
abuse, mental health, diet, physical activity, insomnia, chronic pain, cardiovascular risk, and childhood
health problems), but only few have websites available for public use. A systematic review and meta-
analysis investigating what effect computer-, mobile-, or wearable technology has on reduction of
sedentary behavior reveal that using these tools can reduce mean sitting time by a little over 40 min
per day, but the effects are short-term, and thus not sustained over time [57]. The use of behavioral
change techniques (BCTs) was also investigated in the same study using the BCT taxonomy [58], and
the most frequently used BCTs were “prompts and cues”, “self-monitoring of behavior”, “social sup-
port”, and “goal setting” [57]. In order to promote adherence or maintenance of behaviors, other BCTs
needs to be added to the interventions.
There are some systematic reviews of digital interventions in this field of people with RMDs. The
review by Srikesavan et al. [59] focuses on web-based rehabilitation interventions in patients with RA
and concludes that the effects on pain, function, quality of life, self-efficacy, RA knowledge, physical
activity, and adverse effects in people with RA are uncertain because of the very low quality of evi-
dence. Only two outcomes showed significant improvements with web-based rehabilitation in-
terventions, self-efficacy, and RA patient knowledge, but the quality of this evidencewas very low. They
also conclude that adverse effects of web-based interventions have not been evaluated [59]. The review
by Griffiths et al. [60] focuses specifically on digital interventions for physical activity in patients with
inflammatory arthritis (IA) and their findings suggest that the evidence for the effect of digital in-
terventions on PA behavior is very limited. In this study, the authors also note the low adherence to PA
interventions among the patient group and that future studies should focus on longer follow ups. In
osteoarthritis, there is some evidence for the value of digital interventions in disease management. A
review describing the results from 7 RCTs concluded that digital technology-supported interventions
resulted in less pain, improved physical function, and improved health-related quality of life compared
to no intervention. The improvements, however, were small and future research highlighting patients’
adherence to digital interventions is promoted again [61]. The review by Berry et al. concluded that
digital interventions have short-term positive effect on levels of physical activity but agreed that the
long-term adherence is unknown and needs attention in future studies [62].
Digital technology to support adherence
Improving outcomes for people with RMDs in the longer term is a key focus for clinicians, with the
incorporation of digital technologies monitoring in healthcare offering benefits for optimizing
adherence and maintenance. Improving physical activity and other lifestyle changes such as reducing
body weight involve significant behavior change with maintenance of the new behaviors in the long
term.
Clinicians maywish to know about patient adherence to the intervention as prescribed/delivered as
well as knowing if a patient has maintained some gains/benefits obtained from the intervention.
Digital technologies offer opportunities for determining if a patient is adhering to a particular regime
and also to determine if changes in outcomes are adhered to in the long term. So, how can digital
technologies support adherence beyond the intervention period? Key questions for clinicians are how
to support adherence to interventions as prescribed and how to monitor longer-term adherence post
an intervention.
Incorporation of digital technology into a behavior change intervention (DBCI) offers solutions to
the many reported barriers of face to face interventions including reduced cost, individualized treat-
ments, and easily accessed format of information [63e65]. The recent systematic review of DBCIs to
facilitate physical activity in osteoarthritis [62] reported that while existing DBCIs have short term
benefits, their longer-term effect are not known. Their review included nine studies that aimed to
increase PA in adults with OA using interventions delivered by digital platforms (apps and web-based
programs). The DBCIs were found to have a positive effect on PA for up to 12 months post-intervention
showing the benefit such interventions can have. Interventions like these are a valuable adjunct to
clinical care particularly in primary care settings where long waiting lists often prevent people with OA
from having regular care.
B.A. Esbensen et al. / Best Practice & Research Clinical Rheumatology 34 (2020) 1015256In considering how to design a web-based intervention or what intervention to choose in clinical
practice, a number of recent studies provide some answers. Kelders et al. [66] developed a regression
model to predict the factors linked to variance in adherence and found that an RCT study as opposed to
an observational study, increased interaction with a counsellor, more frequent intended usage, more
frequent updates, and more extensive employment of dialogue support significantly predicted better
adherence to aweb-intervention. Thus, these characteristics may be important factors to look for when
choosing a web-intervention to improve adherence.
Considering the nature of the material and how it is presented is also important and the addition of
gamification to the delivery of the content is valuable. Gamification is the application of game design
elements in a nongame context [67] and shares common elements (flow, meaningful rewards, and social
interaction)with behavior change approaches [68]. In examining social support and gamification features
on behavioral and health outcomes in arthritis, a Swiss study (n ¼ 157 patients with RA) allocated to
participants four experimental conditions with different types of access to online social support and
gamification featureswith a control group that had no access to thewebsite [69]. The study demonstrated
the benefit of a web-based interventionwith social support sections on the website leading to decreased
health care utilization and medication overuse and increased empowerment. Gamification alone or with
social support increased physical activity and empowerment and decreased health care utilization.
Less sophisticated digital supports to improve adherence have also been examined in the literature.
A systematic review [70] of 107 articles evaluating the effectiveness of mHealth in supporting the
adherence of patients to chronic diseases management found that SMS was the most frequent mobile
adherence tool used in 40.2% of studies. Of the studies (n ¼ 27) that employed a randomized controlled
trial (RCT) design, themajority (n¼ 15) demonstrated significant improvements in impact on adherence
behaviors. Of the other RCTs that measured effects on disease-specific clinical outcomes (n ¼ 41), only
16 reported significant improvements between groups. A Cochrane review to assess the effects of
mobile phone messaging applications in facilitating self-management of long-term illnesses concluded
that there were some limited indications that mobile phone messaging is helpful in supporting self-
management in long term illnesses [71]. While no participants with arthritis were included in the
Cochrane review, the conclusions drawn from participants with asthma, diabetes, and hypertension
may offer some value for other chronic illness populations. The use of tailored text messages after three
motivational counselling sessions aimed to reduce sedentary time by increasing time in light to mod-
erate intensity was found to be sustained 18months after the initial intervention in peoplewith RA [72].
In summary, the addition of any digital elements to an intervention designed to improve participation or
to monitor adherence to an intervention may be beneficial.
Patients’ experiences of digital technology
In order to administer the right technology with the right timing to the right population, both
health care providers' and patients' satisfaction with the digital interventions need to be understood
[73]. Several studies have investigated patients’ experiences and perspectives of different digital health
tools and programs [74e82]. Themes that arose from the different studies and fromwhichwe can learn
were; moderators are appreciated in online discussions to steer conversations [74], web-pages need to
feel reliablewhichwas felt if e.g. they are hosted by a university [74], interactionwith competent health
professionals promotes use of digital technologies [75,76], the easy access and possibility to use at your
own convenience and pace is very positive [75,76], it saves time [77], and young people often prefer
digital solutions to improve access to resources [82]. However, it also becomes evident that there is still
a strong wish to meet a health professional face-to-face during some point of the intervention, most
often before it starts [75,77].
Patients frequently ask what the best app is for managing their arthritis. Answering that question
can be very difficult due to thewide range of apps available, the clinician's knowledge of such apps, and
how to know what makes a good app. In trying to understand what self-management apps patients
with arthritis most value, Geuens et al. [83] interviewed 31 adult patients using a mixed-methods
approach and asked them to rate app features. In general, participants favored the use of features
pertaining to supporting active and direct diseasemanagement, which help them to keep a closewatch
on their disease status, inform their health care professional, and receive personalized information.
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provided incentivization for disease-related actions (e.g., being able to compare yourself with other
patients, cooperating toward a common goal, and receiving encouragement from friends and/or
family). These dislikes reflect the individual experiences of patients with arthritis and different patient
and social environment manifestations of the condition.
Summary
Primary prevention of RMDs and clinical prevention when people are diagnosed with RMDs are
important in the management of these conditions. Disease prevention and not smoking is of high
importance. In terms of clinical prevention, it is essential that patients with RMDs are involved in their
own disease management and well-informed about the risks of continued smoking- both in terms of
risk of developing CVDs and the risk of not gaining the best possible benefit from the medical treat-
ment. Self-management is very important inmanaging any chronic disease and should be a focus in the
tertiary prevention. Tertiary prevention focuses on limiting the influence of a recognized or verified
disease and preventing further development or worsening of the disease, including physical and
psychosocial disability. Other core aspects in tertiary prevention are physical activity and pain man-
agement. For all three aspects, there is a large body of evidence supporting the effects of such in-
terventions. To make these interventions available to a larger audience, digital technologies can be
used. Based on research in the general population, digital solutions for tertiary prevention are effective.
The available evidence for digital tertiary prevention for peoplewith RMDs is currently weak. However,
the large amount of registered study protocols on this topic suggest an increase in publications in the
coming years. It is well established that the digital Chronic Disease Self-Management Program and
digital interventions in osteoarthritis are effective to improve physical activity level, pain, function, and
quality of life. In designing digital interventions, patients’ experiences and perceptions should be taken
into account in order to enhance usability.
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- Early diagnosis and smoking cessation (or not starting to smoke at all) can improve devel-
opment of disease and prognosis and should therefore be prioritized.
- In order to limit the influence of a recognized or verified disease, and to prevent further
development or worsening of the disease, self-management, physical activity, and pain
management should be promoted by health care providers.
- To increase patient activation and involvement, which is key for sustainability, behavior
change, and self-management, clinical care needs to be individualized and patient centered.
Research agenda
- In order to increase the knowledge base regarding the use of digital technologies in tertiary
prevention interventions in RMDs, high quality research needs to investigate theory-based
and patient centered interventions.
- More research is needed on aspects of adherence and maintenance after tertiary prevention
interventions.
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